Source: Annual Congress 2004 - Assessment and outcome of pulmonary rehabilitation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Archinucci, M. Biagini, R. Scala, M. Nucci, P. Baldi, M. Naldi (Arezzo, Italy). Two versus three months rehabilitation with the same number of sessions in patients with moderate to severe COPD: analysis of the results. Eur Respir J 2004; 24: Suppl. 48, 1596

Member's Comments

No comment yet.

Related content which might interest you: Predictors of benefit persistence after 6 months from a pulmonary rehabilitation programme in moderate-severe COPD patients Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients Year: 2008 Direct cost analysis of COPD patients: A 1 year follow-up study Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Effectiveness of a 24 month INTERdisciplinary COMmunity-based COPD lifestyle program (INTERCOM) in patients with moderate COPD Source: Annual Congress 2008 - Rehabilitation and influencing factors Year: 2008 Four years follow-up of exacerbations in a cohort of COPD patients: 1 year interim results (EXACO study) Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 Repeated pulmonary rehabilitation program (PRP) in severe and disabled COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 69s Year: 2005 An increase in steps per day 6 weeks after pulmonary rehabilitation of COPD patients correlates with an improvement in quality of life Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation Year: 2020 What is the best frequency of exercise training in patients with moderate-to-severe COPD ? Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation Year: 2018 Effects of the home-realized 6 months follow-up study individually designed exercise programme on patients with severe chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 556s Year: 2006 Long-term benefits of pulmonary rehabilitation in COPD patients: 2 year follow-up Source: International Congress 2017 – Novel treatments for rehabilitation of patients with chronic respiratory diseases Year: 2017 A disease specific self-management intervention reduces hospital utilization in patients with COPD: a sustained effect at 2 years Source: Eur Respir J 2003; 22: Suppl. 45, 347s Year: 2003 Targeted lung denervation in patients with moderate to severe COPD: AIRFLOW-2 crossover patient outcomes. Source: Virtual Congress 2020 – The hot and cold of interventional pulmonology Year: 2020 Bronchodilation or pulmonary rehabilitation:which test of exercise performance yields the greatest response for patients with stable COPD? An RCT. Source: International Congress 2018 – Additional latest insights in pulmonary rehabilitation for chronic lung diseases Year: 2018 Comparison of 2 different modalities to determine training intensity in moderate intensity continuous (MIC) and high intensity interval (HIT) treadmill walking in patients with severe COPD - A pilot feasibility study Source: International Congress 2016 – Effects of exercise training interventions in chronic respiratory disease Year: 2016 A seven week out patient pulmonary rehabilitation programme versus a four week out patient pulmonary rehabilitation programme: results at six months Source: Eur Respir J 2005; 26: Suppl. 49, 68s Year: 2005 COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD Source: ERJ Open Res, 7 (1) 00718-2020; 10.1183/23120541.00718-2020 Year: 2021 Changes of quality of life after short rehabilitation treatment in COPD patients: comparison between three groups of different age Source: Eur Respir J 2006; 28: Suppl. 50, 556s Year: 2006 Prevalence of heart disease in patients hospitalized for an acute exacerbation of COPD: Impact on clinical outcome. A 6 month follow-up study Source: Annual Congress 2011 - COPD management Year: 2011 Late Breaking Abstract - Danirixin (GSK1325756) improves respiratory symptoms and health status in mild to moderate COPD – results of a 1 year first time in patient study Source: International Congress 2017 – Primary care management of respiratory symptoms, allergies, inhalers and adherence Year: 2017 Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses Source: ERJ Open Res, 4 (2) 00119-2017; 10.1183/23120541.00119-2017 Year: 2018 Long-term (1-year) effects of two methods of exercise training (ET) in COPD patients Source: Annual Congress 2010 - Exercise in COPD Year: 2010